01—Abstract
Summary
Summary of the 10-Q filed November 5, 2025. Cited figures are marked; the original filing is the authoritative source.
Astera Labs, Inc. (ALAB) reported a strong third quarter of 2025, demonstrating significant year-over-year growth.
Total revenue surged by 104% to $230.6 milliona for the three months ended September 30, 2025, and by 128% to $581.9 million for the first nine months of the year, primarily driven by increased unit shipments and a favorable product mix. The company achieved profitability in the current quarter and year-to-date, a significant turnaround from the previous year.
This operational improvement is underpinned by robust demand for its Intelligent Connectivity Platform, serving hyperscalers and AI infrastructure needs. Despite increased operating expenses related to headcount growth and R&D initiatives, the company's strategic investments appear to be paying off, with a healthy increase in operating income and a positive net income of $91.1 millionb for the quarter.
02—Key points
Key Highlights
- Revenue growth accelerated significantly, with a 104% increase in the third quarter of 2025 compared to the prior year, reaching $230.6 million.
- For the nine months ended September 30, 2025, revenue more than doubled, increasing by 128% to $581.9 million.
- The company has transitioned to profitability, reporting a net income of $91.1 million for the third quarter of 2025, a substantial improvement from a net loss in the same period last year.
- Gross margin remains strong, albeit slightly decreased to 76.2% for the quarter, reflecting a favorable product mix shift towards hardware modules.
- Operating expenses increased due to strategic investments in headcount and R&D, but were partially offset by a decrease in non-cash stock-based compensation.
- Cash and cash equivalents, along with marketable securities, stood at a robust $1.13 billion as of September 30, 2025, providing ample liquidity.
- The company reported material weaknesses in internal control over financial reporting, with ongoing remediation efforts.
03—One dollar
Follow one dollar
Of each $1.00 of revenue in Q3 FY2025, Astera Labs kept $0.40.
- Revenue$230.6M100.0%
- Cost of revenue−$54.8M23.8%
- Gross profit$175.8M76.2%
- Operating costs−$120.4M52.2%
- Operating income$55.4M24.0%
- Interest, other & tax$35.7M15.5%
- Net income$91.1M39.5%
04—Financials
Financial Highlights
Figures from 10-QQ3 FY2025filed November 5, 2025Financial Statements
Q3 FY2025 against Q3 FY2024
| Line item | Q3 FY2025Q3 FY2024 | Change |
|---|---|---|
| Revenue | $230.57M$113.09M | +103.9% |
| Cost of Revenue | $54.76M$25.21M | +117.2% |
| Gross Profit | $175.81M$87.88M | +100.1% |
| R&D Expenses | $78.93M$50.66M | +55.8% |
| Operating Expenses | $120.41M$96.77M | +24.4% |
| Operating Income | $55.41M-$8.90M | +722.8% |
| Net Income | $91.11M-$7.59M | +1300.0% |
| EPS (Basic) | $0.54$-0.05 | +1180.0% |
| EPS (Diluted) | $0.50$-0.05 | +1100.0% |
| Shares Outstanding (Basic) | 167.44M156.83M | +6.8% |
| Shares Outstanding (Diluted) | 180.63M156.83M | +15.2% |
05—Questions
Frequently Asked Questions
What is driving Astera Labs' significant revenue growth?
Astera Labs' substantial revenue growth is primarily driven by an increase in overall unit shipments, fueled by high demand for its Aries, Scorpio, and Taurus products. Additionally, a shift in product mix towards higher-priced hardware modules and Scorpio products has contributed to higher average selling prices.
Has Astera Labs achieved profitability, and what is the outlook?
Yes, Astera Labs has achieved profitability. The company reported a net income of $91.1 million for the three months ended September 30, 2025, and $174.2 million for the nine months ended September 30, 2025. This marks a significant turnaround from the net losses reported in the comparable periods of 2024. The company believes its current cash position is sufficient to fund operations for at least the next 12 months and beyond.
What are the key challenges or concerns highlighted in the filing?
The primary concern highlighted is the existence of material weaknesses in the company's internal control over financial reporting, related to inadequate risk assessment processes and information technology general controls. Astera Labs is actively engaged in remediation efforts to address these issues, but they remain unremediated as of the reporting date. Investors should monitor the progress of these remediation efforts.
How has stock-based compensation impacted the financial results?
Stock-based compensation expense has decreased significantly, particularly for the nine-month period ended September 30, 2025, compared to 2024. This decrease is largely due to the recognition of time-based vesting of Restricted Stock Units (RSUs) following the company's IPO in the prior year. While operating expenses have increased due to headcount and R&D, the reduction in stock-based compensation has helped offset some of these increases and contributed positively to net income.
06—Continue